BRAF and ameloblastoma: It is notable that the KRAS p.G12R mutation, which occurs in adenomatoid odontogenic tumors [12], has been reported in 4/50 (8%) [52] and 4/28 (14%) [51] of BRAF wild-type ameloblastoma cases.